- Home
- / Shanxi C&y Pharmaceutical
Shanxi C&y Pharmaceutical
Stock Price
¥9.6
2024-10-29
Market Capitalization
¥2.3 B
2024-10-29
Revenue
¥831 M
FY, 2024
Shanxi C&y Pharmaceutical Summary
Company Summary
- Overview
- Shanxi C&y Pharmaceutical (山西仟源医药集团股份有限公司) is a company that develops, produces, and sells pharmaceutical products. It offers anti-infectious medicine, vitamin tablets, injections, dermatology products, etc.
- Type
- Public
- Status
- Active
- Founded
- 2005
- Website
- http://cy-pharm.com
- Cybersecurity rating
Table of Contents
Shanxi C&y Pharmaceutical Financials
Summary Financials
- Revenue (Q3, 2025)
- ¥237.2M
- Gross profit (Q3, 2025)
- ¥154.2M
- Net income (Q3, 2025)
- ¥32.1M
- Cash (Q3, 2025)
- ¥129.0M
- EBIT (Q3, 2025)
- ¥46.1M
- Enterprise value
- $2.9B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026